#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cataract Neoplasm Drug eruption Trigeminal neuralgia Biliary neoplasm Juvenile idiopathic arthritis Enteritis Henoch-Schonlein purpura Follicle centre lymphoma follicular grade I, II – III Angiosarcoma recurrent Liposarcoma metastatic Infantile apnoea Thrombotic thrombocytopenic purpura Vernal keratoconjunctivitis Canavan disease More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic – Diagnostics Methylmalonic acidaemia – Life with Disease Mantle cell lymphoma stage III – Basic Information Chordoma Crigler-Najjar syndrome – Trials in Disease Haemophilia B with anti factor IX – Diagnostics Ewing’s sarcoma metastatic – Treatment Haemophilia A with anti factor VIII – Trials in Disease Uterine leiomyosarcoma – Trials in Disease Proteus syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GS-248 Vx-522 ZILUCOPLAN Sulfamethoxazole Garadacimab Navitoclax Gadoquatrane Alx148 Mps-213 Lurasidone Cloxacillin Ibuprofen Sodium Dihydrate Diacerein Latozinemab Setmelanotide Fosphenytoin Sodium Doxycycline Hyclate Sodium Sulfate Anhydrous Dfv890 Tilmanocept More therapies…

    Learn about Your Condition

    Polycystic liver disease Peripheral artery restenosis Cervix carcinoma recurrent Spinal osteoarthritis Obstructive pancreatitis Tuberculosis Eosinophilic gastritis Neonatal respiratory failure Mental disorder Osteoarthritis Vulvovaginal candidiasis Thalassaemia alpha Kawasaki's disease Langerhans cell sarcoma Retinitis pigmentosa More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Barzolvolimab in Adults with Active Eosinophilic Esophagitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Eosinophilic oesophagitis
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Germany Italy Poland Spain

  • Study on the Effects of Etavopivat for Patients Aged 12-65 with Sickle Cell Disease

    Not recruiting

    4 1
    Investigated Diseases:
    • Sickle cell disease
    Investigated Drugs:
    • Etavopivat
    France Germany Greece Italy Spain

  • Study of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Anifrolumab
    Austria Belgium France Germany Hungary Italy +4

  • Study on the Effects of GS-5290 for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    2 1
    Investigated Drugs:
    • (Phosphonooxy)Methyln-[(S)-[1-(Bicyclo[1.1.1]Pentan1-Yl)-1H-1,2,3-Triazol-4-Yl](2-Methyl-1-Oxo-1,2-Dihydroisoquinolin-5-Yl)Methyl]-N-{8-Chloro-3-Cyano-4-[(2,2-Dimethylpropyl)Amino]Quinolin-6-Yl]Carbamate
    Austria Belgium France Germany Hungary Italy +1

  • Study on ARGX-117 for Improving Kidney Function in Patients with Delayed Graft Function After Deceased Donor Transplant

    Not recruiting

    2 1
    Investigated Drugs:
    • Empasiprubart
    Austria Belgium France Italy Portugal Spain +1

  • Study on the Safety and Effectiveness of Dupilumab for Adults and Adolescents with Eosinophilic Gastritis and Eosinophilic Duodenitis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Dupilumab
    France Italy Poland

  • Study of RVT-3101 for Treating Moderate to Severe Crohn’s Disease in Patients

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Pf-06480605
    • Ro7790121
    Belgium Bulgaria Czechia France Germany Hungary +5

  • Study on the Safety and Effectiveness of R2R01 and Terlipressin for Patients with Hepatorenal Syndrome and Acute Kidney Injury

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute kidney injury
    • Hepatorenal syndrome
    Investigated Drugs:
    • R2R01
    • Terlipressin Acetate
    Germany Italy

  • Study on the Safety and Effects of Garadacimab for Preventing Hereditary Angioedema in Children Aged 2 to 11

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hereditary angioedema
    Investigated Drugs:
    • Garadacimab
    Germany Italy

  • Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

    Not recruiting

    3 1
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia Estonia France Germany +10
Previous Page
1 … 35 36 37 38 39 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!